{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:21:56Z","timestamp":1790634116791,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000993","name":"Battelle","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000993","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.yrtph.2020.104750","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T21:36:57Z","timestamp":1596231417000},"page":"104750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Evaluation of chronic toxicity of cyclocreatine, a creatine analog, in Sprague Dawley rat after oral gavage administration for up to 26 weeks"],"prefix":"10.1016","volume":"117","author":[{"given":"Vijay Pralhad","family":"Kale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery","family":"Wallery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Bourdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh-Ha T.","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"McKew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod S.","family":"Terse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.yrtph.2020.104750_bib1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/syn.20280","article-title":"Exocytotic release of creatine in rat brain","volume":"60","author":"Almeida","year":"2006","journal-title":"Synapse"},{"issue":"9","key":"10.1016\/j.yrtph.2020.104750_bib2","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1016\/S0021-9258(19)85614-4","article-title":"Energy metabolism of skeletal muscle containing cyclocreatine phosphate. Delay in onset of rigor mortis and decreased glycogenolysis in response to ischemia or epinephrine","volume":"255","author":"Annesley","year":"1980","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.yrtph.2020.104750_bib3","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00726-011-0851-0","article-title":"Neuroprotective effects of creatine","volume":"40","author":"Beal","year":"2011","journal-title":"Amino Acids"},{"issue":"2","key":"10.1016\/j.yrtph.2020.104750_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1471-4159.2010.06935.x","article-title":"Synthesis and transport of creatine in the cns: importance for cerebral functions","volume":"115","author":"Beard","year":"2010","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.yrtph.2020.104750_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0005-2728(96)00018-7","article-title":"The utilisation of creatine and its analogues by cytosolic and mitochondrial creatine kinase","volume":"1274","author":"Boehm","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.yrtph.2020.104750_bib6","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1177\/0192623312474865","article-title":"STP position paper: recommended practices for sampling and processing the nervous system (brain, spinal cord, nerve, and eye) during nonclinical general toxicity studies","volume":"41","author":"Bolon","year":"2013","journal-title":"Toxicol. Pathol."},{"issue":"3","key":"10.1016\/j.yrtph.2020.104750_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1939-165X.2005.tb00041.x","article-title":"Selection and interpretation of clinical pathology indicators of hepatic injury in preclinical studies","volume":"34","author":"Boone","year":"2005","journal-title":"Vet. Clin. Pathol."},{"issue":"3 Suppl. l","key":"10.1016\/j.yrtph.2020.104750_bib8","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1293\/tox.31.1S","article-title":"Nonproliferative and proliferative lesions of the rat and mouse endocrine system","volume":"31","author":"Brandli-Baiocco","year":"2018","journal-title":"J. Toxicol. Pathol."},{"issue":"6 Suppl. l","key":"10.1016\/j.yrtph.2020.104750_bib9","doi-asserted-by":"crossref","first-page":"40S","DOI":"10.1177\/0192623312454337","article-title":"Proliferative and nonproliferative lesions of the rat and mouse male reproductive system","volume":"40","author":"Creasy","year":"2012","journal-title":"Toxicol. Pathol."},{"issue":"6","key":"10.1016\/j.yrtph.2020.104750_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/1759091414554945","article-title":"Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an in vitro Parkinson's model","volume":"6","author":"Cunha","year":"2014","journal-title":"ASN Neuro."},{"issue":"2","key":"10.1016\/j.yrtph.2020.104750_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-201x.2001.00786.x","article-title":"Effect of creatine supplementation on creatine and glycogen content in rat skeletal muscle","volume":"171","author":"Eijnde","year":"2001","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.yrtph.2020.104750_bib12","series-title":"21 CFR. Part 58. Good Laboratory Practice for Nonclinical Laboratory Studies","author":"FDA","year":"2019"},{"key":"10.1016\/j.yrtph.2020.104750_bib13","series-title":"Guides for Toxicologic Pathology","article-title":"Non-proliferative lesions of the endocrine system in rats, E-1","author":"Frith","year":"2000"},{"issue":"6","key":"10.1016\/j.yrtph.2020.104750_bib14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/1091581818796444","article-title":"\u201cNot everything that shakes is a seizure\u201d: making the determination of test article-induced convulsions in toxicology studies","volume":"37","author":"Gauvin","year":"2018","journal-title":"Int. J. Toxicol."},{"issue":"4","key":"10.1016\/j.yrtph.2020.104750_bib15","first-page":"1339","article-title":"Antiproliferative effects of cyclocreatine on human prostatic carcinoma cells","volume":"15","author":"Hoosein","year":"1995","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.yrtph.2020.104750_bib16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1939-165X.2009.00143.x","article-title":"Effect of fasting duration on clinical pathology results in wistar rats","volume":"38","author":"Kale","year":"2009","journal-title":"Vet. Clin. Pathol."},{"key":"10.1016\/j.yrtph.2020.104750_bib17","doi-asserted-by":"crossref","first-page":"104483","DOI":"10.1016\/j.yrtph.2019.104483","article-title":"Preclinical toxicity evaluation of JD5037, a peripherally restricted CB1 receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis","volume":"109","author":"Kale","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2020.104750_bib18","series-title":"Animal Electrophysiology","author":"Klemm","year":"1969"},{"issue":"8","key":"10.1016\/j.yrtph.2020.104750_bib19","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1172\/JCI59373","article-title":"Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency","volume":"122","author":"Kurosawa","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"13","key":"10.1016\/j.yrtph.2020.104750_bib20","first-page":"3172","article-title":"Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors","volume":"53","author":"Lillie","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.yrtph.2020.104750_bib21","series-title":"Thyroid gland, follicle \u2013 mineralization","article-title":"NTP nonneoplastic lesion atlas","author":"Maronpot","year":"2019"},{"issue":"8","key":"10.1016\/j.yrtph.2020.104750_bib22","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jnci\/86.8.608","article-title":"Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumor cells","volume":"86","author":"Martin","year":"1994","journal-title":"J. Natl. Cancer Inst."},{"issue":"19","key":"10.1016\/j.yrtph.2020.104750_bib23","first-page":"5160","article-title":"Cell cycle studies of cyclocreatine, a new anticancer agent","volume":"54","author":"Martin","year":"1994","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.yrtph.2020.104750_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/10915819609008716","article-title":"A performance standard for clinical and functional observational battery examinations of rats","volume":"15","author":"Mattsson","year":"1996","journal-title":"J. Am. Coll. Toxicol."},{"issue":"19","key":"10.1016\/j.yrtph.2020.104750_bib25","doi-asserted-by":"crossref","first-page":"12034","DOI":"10.1016\/S0021-9258(20)71316-5","article-title":"Repression of rat kidney l-arginine:Glycine amidinotransferase synthesis by creatine at a pretranslational level","volume":"259","author":"McGuire","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yrtph.2020.104750_bib26","series-title":"Simultaneous Statistical Inference","author":"Miller","year":"1981"},{"key":"10.1016\/j.yrtph.2020.104750_bib27","series-title":"X-linked Creatine Deficiency","author":"NLM","year":"2019"},{"key":"10.1016\/j.yrtph.2020.104750_bib28","series-title":"Creatine Transporter Deficiency","author":"NORD","year":"2020"},{"key":"10.1016\/j.yrtph.2020.104750_bib29","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"issue":"11","key":"10.1016\/j.yrtph.2020.104750_bib30","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.WCB.0000033966.83623.7D","article-title":"The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain","volume":"22","author":"Ohtsuki","year":"2002","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"6","key":"10.1016\/j.yrtph.2020.104750_bib31","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0192623316642527","article-title":"Characterizing \"adversity\" of pathology findings in nonclinical toxicity studies: results from the 4th estp international expert workshop","volume":"44","author":"Palazzi","year":"2016","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"10.1016\/j.yrtph.2020.104750_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1550-2783-7-6","article-title":"Creatine supplementation spares muscle glycogen during high intensity intermittent exercise in rats","volume":"7","author":"Roschel","year":"2010","journal-title":"J. Int. Soc. Sports Nutr."},{"issue":"6","key":"10.1016\/j.yrtph.2020.104750_bib33","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/320595","article-title":"X-linked creatine-transporter gene (slc6a8) defect: a new creatine-deficiency syndrome","volume":"68","author":"Salomons","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.yrtph.2020.104750_bib34","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/B978-0-444-59565-2.00053-8","article-title":"Creatine deficiency syndromes","volume":"113","author":"Schulze","year":"2013","journal-title":"Handb. Clin. Neurol."},{"issue":"5","key":"10.1016\/j.yrtph.2020.104750_bib35","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/01926230701595300","article-title":"Society of toxicologic pathology position paper: organ weight recommendations for toxicology studies","volume":"35","author":"Sellers","year":"2007","journal-title":"Toxicol. Pathol."},{"issue":"4","key":"10.1016\/j.yrtph.2020.104750_bib36","first-page":"843","article-title":"Creatine revealed anticonvulsant properties on chemically and electrically induced seizures in mice","volume":"15","author":"Shafaroodi","year":"2016","journal-title":"Iran. J. Pharm. Res. (IJPR)"},{"issue":"1\u20132","key":"10.1016\/j.yrtph.2020.104750_bib37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1011908606819","article-title":"Creatine and the creatine transporter: a review","volume":"224","author":"Snow","year":"2001","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.yrtph.2020.104750_bib38","doi-asserted-by":"crossref","first-page":"875","DOI":"10.18388\/abp.2004_3520","article-title":"Biochemical and clinical characteristics of creatine deficiency syndromes","volume":"51","author":"Sykut-Cegielska","year":"2004","journal-title":"Acta Biochim. Pol."},{"issue":"5","key":"10.1016\/j.yrtph.2020.104750_bib39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s002800050255","article-title":"Cyclocreatine in cancer chemotherapy","volume":"35","author":"Teicher","year":"1995","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2020.104750_bib40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1042\/CS20030116","article-title":"Creatine supplementation increases glycogen storage but not glut-4 expression in human skeletal muscle","volume":"106","author":"van Loon","year":"2004","journal-title":"Clin. Sci. (Lond.)"},{"issue":"5","key":"10.1016\/j.yrtph.2020.104750_bib41","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1471-4159.1980.tb09966.x","article-title":"Utilization of cyclocreatine phosphate, and analogue of creatine phosphate, by mouse brain during ischemia and its sparing action on brain energy reserves","volume":"34","author":"Woznicki","year":"1980","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.yrtph.2020.104750_bib42","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","article-title":"Creatine and creatinine metabolism","volume":"80","author":"Wyss","year":"2000","journal-title":"Physiol. Rev."},{"issue":"23","key":"10.1016\/j.yrtph.2020.104750_bib43","doi-asserted-by":"crossref","first-page":"13435","DOI":"10.1074\/jbc.271.23.13435","article-title":"Phosphocreatine-dependent glutamate uptake by synaptic vesicles. A comparison with ATP-dependent glutamate uptake","volume":"271","author":"Xu","year":"1996","journal-title":"J. Biol. Chem."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230020301768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230020301768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:30:03Z","timestamp":1759494603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230020301768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":43,"alternative-id":["S0273230020301768"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2020.104750","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of chronic toxicity of cyclocreatine, a creatine analog, in Sprague Dawley rat after oral gavage administration for up to 26 weeks","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2020.104750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104750"}}